Literature DB >> 28528674

Sodium Channels and Venom Peptide Pharmacology.

Mathilde R Israel1, Bryan Tay1, Jennifer R Deuis2, Irina Vetter3.   

Abstract

Venomous animals including cone snails, spiders, scorpions, anemones, and snakes have evolved a myriad of components in their venoms that target the opening and/or closing of voltage-gated sodium channels to cause devastating effects on the neuromuscular systems of predators and prey. These venom peptides, through design and serendipity, have not only contributed significantly to our understanding of sodium channel pharmacology and structure, but they also represent some of the most phyla- and isoform-selective molecules that are useful as valuable tool compounds and drug leads. Here, we review our understanding of the basic function of mammalian voltage-gated sodium channel isoforms as well as the pharmacology of venom peptides that act at these key transmembrane proteins.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Conotoxins; Gating modifier toxins; Pore blockers; Scorpion toxins; Spider venom peptides; Venom peptide; Voltage-gated sodium channel

Mesh:

Substances:

Year:  2017        PMID: 28528674     DOI: 10.1016/bs.apha.2017.01.004

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 1054-3589


  16 in total

1.  Comprehensive engineering of the tarantula venom peptide huwentoxin-IV to inhibit the human voltage-gated sodium channel hNav1.7.

Authors:  Robert A Neff; Mack Flinspach; Alan Gibbs; Amy Y Shih; Natali A Minassian; Yi Liu; Ross Fellows; Ondrej Libiger; Stephanie Young; Michael W Pennington; Michael J Hunter; Alan D Wickenden
Journal:  J Biol Chem       Date:  2019-12-23       Impact factor: 5.157

2.  Mapping the Molecular Surface of the Analgesic NaV1.7-Selective Peptide Pn3a Reveals Residues Essential for Membrane and Channel Interactions.

Authors:  Alexander Mueller; Zoltan Dekan; Quentin Kaas; Akello J Agwa; Hana Starobova; Paul F Alewood; Christina I Schroeder; Mehdi Mobli; Jennifer R Deuis; Irina Vetter
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-19

3.  From identification to functional characterization of cyriotoxin-1a, an antinociceptive toxin from the spider Cyriopagopus schioedtei.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michael Kurz; Laetitia Lucarain; Sophie Fouconnier; Stéphanie Combemale; Lucie Jaquillard; Brigitte Schombert; Jean-Marie Chambard; Rachid Boukaiba; Gerhard Hessler; Andrees Bohme; Laurent Bialy; Stéphane Hourcade; Rémy Béroud; Michel De Waard; Denis Servent; Michel Partiseti
Journal:  Br J Pharmacol       Date:  2019-04-09       Impact factor: 8.739

Review 4.  Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7.

Authors:  John V Mulcahy; Hassan Pajouhesh; Jacob T Beckley; Anton Delwig; J Du Bois; John C Hunter
Journal:  J Med Chem       Date:  2019-05-07       Impact factor: 7.446

Review 5.  Status of peripheral sodium channel blockers for non-addictive pain treatment.

Authors:  Matthew Alsaloum; Grant P Higerd; Philip R Effraim; Stephen G Waxman
Journal:  Nat Rev Neurol       Date:  2020-10-27       Impact factor: 42.937

6.  Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer's Disease: Insights from a Synaptic Machinery Perspective.

Authors:  Hamid Ceylan
Journal:  J Mol Neurosci       Date:  2021-08-19       Impact factor: 3.444

7.  Pharmacological Inhibition of the Voltage-Gated Sodium Channel NaV1.7 Alleviates Chronic Visceral Pain in a Rodent Model of Irritable Bowel Syndrome.

Authors:  Yan Jiang; Joel Castro; Linda V Blomster; Akello J Agwa; Jessica Maddern; Gudrun Schober; Volker Herzig; Chun Yuen Chow; Fernanda C Cardoso; Paula Demétrio De Souza França; Junior Gonzales; Christina I Schroeder; Steffen Esche; Thomas Reiner; Stuart M Brierley; Glenn F King
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-07

8.  Small cyclic sodium channel inhibitors.

Authors:  Steve Peigneur; Cristina da Costa Oliveira; Flávia Cristina de Sousa Fonseca; Kirsten L McMahon; Alexander Mueller; Olivier Cheneval; Ana Cristina Nogueira Freitas; Hana Starobova; Igor Dimitri Gama Duarte; David J Craik; Irina Vetter; Maria Elena de Lima; Christina I Schroeder; Jan Tytgat
Journal:  Biochem Pharmacol       Date:  2020-10-17       Impact factor: 6.100

Review 9.  Pain-Causing Venom Peptides: Insights into Sensory Neuron Pharmacology.

Authors:  Sina Jami; Andelain Erickson; Stuart M Brierley; Irina Vetter
Journal:  Toxins (Basel)       Date:  2017-12-27       Impact factor: 4.546

10.  Aspartic Acid Isomerization Characterized by High Definition Mass Spectrometry Significantly Alters the Bioactivity of a Novel Toxin from Poecilotheria.

Authors:  Stephen R Johnson; Hillary G Rikli
Journal:  Toxins (Basel)       Date:  2020-03-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.